Tealwood Asset Management Inc. Sells 2,982 Shares of Cooper Companies Inc (NYSE:COO)
Tealwood Asset Management Inc. cut its holdings in Cooper Companies Inc (NYSE:COO) by 23.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 9,658 shares of the medical device company’s stock after selling 2,982 shares during the period. Cooper Companies accounts for approximately 1.3% of Tealwood Asset Management Inc.’s portfolio, making the stock its 26th biggest holding. Tealwood Asset Management Inc.’s holdings in Cooper Companies were worth $3,254,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Swiss National Bank increased its stake in Cooper Companies by 2.7% during the first quarter. Swiss National Bank now owns 214,000 shares of the medical device company’s stock valued at $63,380,000 after acquiring an additional 5,700 shares during the period. Wealthfront Advisers LLC increased its stake in Cooper Companies by 31.2% during the first quarter. Wealthfront Advisers LLC now owns 1,536 shares of the medical device company’s stock valued at $455,000 after acquiring an additional 365 shares during the period. Signaturefd LLC increased its stake in Cooper Companies by 3.8% during the second quarter. Signaturefd LLC now owns 875 shares of the medical device company’s stock valued at $295,000 after acquiring an additional 32 shares during the period. State Treasurer State of Michigan increased its stake in Cooper Companies by 1.4% during the first quarter. State Treasurer State of Michigan now owns 14,228 shares of the medical device company’s stock valued at $4,214,000 after acquiring an additional 200 shares during the period. Finally, Envestnet Asset Management Inc. increased its stake in Cooper Companies by 16.0% during the first quarter. Envestnet Asset Management Inc. now owns 55,589 shares of the medical device company’s stock valued at $16,464,000 after acquiring an additional 7,688 shares during the period. Hedge funds and other institutional investors own 96.59% of the company’s stock.
Several equities analysts recently issued reports on the company. Zacks Investment Research upgraded Cooper Companies from a “hold” rating to a “buy” rating and set a $336.00 price target on the stock in a research note on Friday, June 7th. Northcoast Research reaffirmed a “buy” rating and set a $340.00 price objective (up from $331.00) on shares of Cooper Companies in a report on Monday, June 3rd. KeyCorp reaffirmed a “positive” rating and set a $351.00 price objective (up from $314.00) on shares of Cooper Companies in a report on Thursday. Wells Fargo & Co lifted their price objective on Cooper Companies from $356.00 to $365.00 and gave the company an “outperform” rating in a report on Thursday, August 8th. Finally, Piper Jaffray Companies lifted their price objective on Cooper Companies from $330.00 to $360.00 and gave the company an “overweight” rating in a report on Tuesday, August 13th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and eleven have given a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $326.27.
Shares of COO traded down $2.37 on Thursday, hitting $330.24. The company’s stock had a trading volume of 4,481 shares, compared to its average volume of 230,785. The company has a market capitalization of $16.60 billion, a PE ratio of 28.82, a PEG ratio of 2.54 and a beta of 0.90. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.21 and a quick ratio of 0.68. Cooper Companies Inc has a fifty-two week low of $228.65 and a fifty-two week high of $344.32. The company has a 50 day moving average price of $334.05 and a 200 day moving average price of $305.56.
Cooper Companies (NYSE:COO) last announced its earnings results on Thursday, May 30th. The medical device company reported $2.94 EPS for the quarter, topping the consensus estimate of $2.76 by $0.18. Cooper Companies had a return on equity of 17.25% and a net margin of 16.46%. The business had revenue of $654.30 million for the quarter, compared to the consensus estimate of $655.00 million. During the same period in the previous year, the business earned $2.86 EPS. Cooper Companies’s revenue was up 3.6% compared to the same quarter last year. On average, equities analysts forecast that Cooper Companies Inc will post 12.28 EPS for the current year.
The business also recently disclosed a Semi-Annual dividend, which was paid on Wednesday, August 7th. Investors of record on Tuesday, July 23rd were given a $0.03 dividend. The ex-dividend date was Monday, July 22nd. Cooper Companies’s dividend payout ratio (DPR) is presently 0.52%.
Cooper Companies Company Profile
The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.
Featured Article: Outstanding Shares and The Effect on Share Price
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.